Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bruker Cellular Analysis, Inc.CELL · Entity 109250 | Director | October 02, 2023 | October 03, 2023 |
| Catalent, Inc.CTLT · Entity 16279 | Director · Executive Chair | August 24, 2022 | August 27, 2022 |
| QuidelOrtho CorpQDEL · Entity 4986 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bruker Cellular Analysis, Inc.
Report date October 02, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-10-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-10-02 · Disposition to issuer · Disposed 71,225 · Balance 41,240 F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration. Row 2 · 2023-10-02 · Disposition to issuer · Disposed 41,240 · Balance 0 F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration. F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration").
F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration.
F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the Merger Consideration.
F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration.
Catalent, Inc.
Report date August 24, 2022 · Filed August 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 229,888 |
Last balance in matching sequence
After 2022-08-25 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2022-08-24 · Grant · Acquired 99,275 · Balance 268,822 F1: Received upon the achievement of the fiscal 2020-22 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan. F2: Includes restricted stock units. Row 2 · 2022-08-25 · Sale · Disposed 38,934 · Balance 229,888 F3: Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Received upon the achievement of the fiscal 2020-22 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
F2: Includes restricted stock units.
F3: Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
QuidelOrtho Corp
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Equity Grant)SEC Table II · derivative / convertible security | Direct | 15,532 |
Reported balance
After 2026-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 15,532 · Balance 15,532 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. |
| Restricted Stock Units (Converted)SEC Table II · derivative / convertible security | Direct | 5,547 |
Reported balance
After 2026-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-25 · Grant · Acquired 5,547 · Balance 5,547 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027. |
| Restricted Stock Units (Premium)SEC Table II · derivative / convertible security | Direct | 1,109 |
Reported balance
After 2026-06-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-25 · Grant · Acquired 1,109 · Balance 1,109 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2: The restricted stock units will vest on June 25, 2027.
F3: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
F4: 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2021 Filed Mar 22, 2021 18:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 69,270 | $43.88 | $3,039,567.60 |
DisclosureSEC source: 0001596783-21-000045 · wf-form4_161643718240512.xml · nonDerivative · entry 5 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 18:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 45,792 | $34.91 | $1,598,598.72 |
DisclosureSEC source: 0001596783-21-000045 · wf-form4_161643718240512.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 18:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 35,588 | $36.02 | $1,281,879.76 |
DisclosureSEC source: 0001596783-21-000045 · wf-form4_161643718240512.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 18:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 42,220 | $0.00 Strike: $36.02 | $0.00 |
DisclosureSEC source: 0001596783-21-000045 · wf-form4_161643718240512.xml · derivative · entry 10 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,527 Underlying: Common Stock · 42,220 shares Expires 2027-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F8 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 24, 2018. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 18:19 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 42,220 | $105.16 | $4,439,855.20 |
DisclosureSEC source: 0001596783-21-000045 · wf-form4_161643718240512.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,618 F3 · kind: Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F4 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 18:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 42,220 | $36.02 | $1,520,764.40 |
DisclosureSEC source: 0001596783-21-000045 · wf-form4_161643718240512.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| December 17, 2020 Filed Dec 17, 2020 22:53 UTC | Catalent, Inc. CTLT · Entity 16279 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000228 · wf-form4_160824560464788.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,618 F1 · kind: This transaction was a charitable donation effective December 17, 2020 in which no value was received in return. F1 · price: This transaction was a charitable donation effective December 17, 2020 in which no value was received in return. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 37,763 | $0.00 Strike: $24.44 | $0.00 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · derivative · entry 8 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,763 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F8 · derivative.exercise_date: On July 26, 2016, the reporting person was granted options to purchase 151,049 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 26, 2017. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 100,372 | $0.00 Strike: $31.96 | $0.00 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · derivative · entry 7 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,372 shares Expires 2025-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F7 · derivative.exercise_date: On August 27, 2015, the reporting person was granted options to purchase 100,372 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on August 27, 2016. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 173,040 | $86.05 | $14,890,092.00 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · nonDerivative · entry 6 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,618 F4 · kind: Represents shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F6 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $85.57 to $86.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 9,191 | $85.27 | $783,716.57 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · nonDerivative · entry 5 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,658 F4 · kind: Represents shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F5 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.565, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 22,198 | $86.01 | $1,909,249.98 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,849 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 37,763 | $24.44 | $922,927.72 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 64,053 | $86.01 | $5,509,198.53 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,284 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 23:55 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 100,372 | $31.96 | $3,207,889.12 |
DisclosureSEC source: 0001596783-20-000180 · wf-form4_160194209323283.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:22 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 1,631 | $87.71 | $143,055.01 |
DisclosureSEC source: 0001596783-20-000167 · wf-form4_159890892258057.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,965 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:22 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000167 · wf-form4_159890892258057.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,596 F3 · kind: Shares received by the reporting person under the issuer's long-term incentive plan in respect of the fiscal 2017-19 performance period that correct the original vested amount received on August 22, 2019. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:22 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 57,347 | $87.71 | $5,029,905.37 |
DisclosureSEC source: 0001596783-20-000167 · wf-form4_159890892258057.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,753 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:22 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 135,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000167 · wf-form4_159890892258057.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,100 F1 · kind: Received upon the achievement of the fiscal 2018-20 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2020 Filed Aug 24, 2020 22:15 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 4,649 | $86.49 | $402,092.01 |
DisclosureSEC source: 0001596783-20-000125 · wf-form4_159830730323225.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,918 F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 13:02 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 111,762 | $0.00 Strike: $88.10 | $0.00 |
DisclosureSEC source: 0001596783-20-000103 · wf-form4_159645976090559.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,762 Underlying: Common Stock · 111,762 shares Expires 2030-07-30 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 30, 2021. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 13:02 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 20,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000103 · wf-form4_159645976090559.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,567 F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 12:10 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 6,642 | $81.64 | $542,252.88 |
DisclosureSEC source: 0001596783-20-000076 · wf-form4_159593818884281.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,965 F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 11, 2019 Filed Dec 16, 2019 13:46 UTC | Catalent, Inc. CTLT · Entity 16279 | GiftCommon Stock | 9,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000217 · wf-form4_157650395651396.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,607 F1 · kind: This transaction was a charitable donation effective December 11, 2019 in which no value was received in return. F1 · price: This transaction was a charitable donation effective December 11, 2019 in which no value was received in return. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 37,762 | $0.00 Strike: $24.44 | $0.00 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · derivative · entry 7 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,763 Underlying: Common Stock · 37,762 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F5 · derivative.exercise_date: On July 26, 2016, the reporting person was granted options to purchase 151,049 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 26, 2017. (S62) Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 9,790 | $0.00 Strike: $24.26 | $0.00 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · derivative · entry 6 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,790 shares Expires 2024-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F4 · derivative.exercise_date: On October 23, 2014, the reporting person was granted options to purchase 39,160 shares of common stock of the Issuer, which vested and became exercisable in four equal annual installments beginning on October 23, 2015. (S1251) Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 97,043 | $48.84 | $4,739,580.12 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · nonDerivative · entry 5 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,257 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F3 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $48.46 to $49.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 27,087 | $48.84 | $1,322,929.08 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,300 F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 37,762 | $24.44 | $922,903.28 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 7,002 | $48.84 | $341,977.68 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,625 F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 07, 2019 Filed Oct 9, 2019 17:13 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 9,790 | $24.26 | $237,505.40 |
DisclosureSEC source: 0001596783-19-000190 · wf-form4_157064120087023.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:45 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 51,767 | $55.24 | $2,859,609.08 |
DisclosureSEC source: 0001596783-19-000152 · wf-form4_156684873915672.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,837 F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:45 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 119,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000152 · wf-form4_156684873915672.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,604 F1 · kind: Received upon the achievement of the fiscal 2017-19 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the issuer's long-term incentive plan. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 20:19 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 13,333 | $57.26 | $763,447.58 |
DisclosureSEC source: 0001596783-19-000098 · wf-form4_156451797286237.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,384 F1 · balance_after: Includes restricted stock units. Read SEC document |
| July 22, 2019 Filed Jul 25, 2019 00:51 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantOptions to purchase Common Stock · Derivative | 129,497 | $0.00 Strike: $54.94 | $0.00 |
DisclosureSEC source: 0001596783-19-000075 · wf-form4_156401587831687.xml · derivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,497 Underlying: Common Stock · 129,497 shares Expires 2029-07-22 F3 · shares: Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. F4 · derivative.exercise_date: The options vest and become exercisable in four equal annual installments beginning on July 22, 2020. Read SEC document |
| July 22, 2019 Filed Jul 25, 2019 00:51 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 24,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000075 · wf-form4_156401587831687.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,717 F1 · shares: Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 75,524 | $0.00 Strike: $24.44 | $0.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · derivative · entry 13 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,525 Underlying: Common Stock · 75,524 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F8 · derivative.exercise_date: On July 26, 2016, the reporting person was granted options to purchase 151,049 shares of common stock of the Issuer which vest and become exercisable in four equal installments beginning July 26, 2017. (S62) Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 29,370 | $0.00 Strike: $24.26 | $0.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · derivative · entry 12 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,790 Underlying: Common Stock · 29,370 shares Expires 2024-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F7 · derivative.exercise_date: On October 23, 2014, the reporting person was granted options to purchase 39,160 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on October 23, 2015. (S1251) Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 41,464 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · derivative · entry 11 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,464 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F6 · derivative.exercise_date: On July 30, 2014, the reporting person was granted options to purchase 41,464 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 30, 2015. (S1215) Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionOptions to purchase Common Stock · Derivative | 140,000 | $0.00 Strike: $18.71 | $0.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · derivative · entry 10 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 140,000 shares Expires 2023-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F5 · derivative.exercise_date: On June 25, 2013, the reporting person was granted options to purchase 350,000 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments (beginning on June 25, 2014) upon the satisfaction of certain performance criteria. The performance criteria were met in respect of 140,000 options. The remaining 210,000 options have been cancelled. (S1101) Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 130,545 | $45.32 | $5,916,299.40 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 9 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,690 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F4 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $45.06 to $45.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 55,839 | $45.32 | $2,530,623.48 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 8 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,235 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 75,524 | $24.44 | $1,845,806.56 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 7 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 21,652 | $45.32 | $981,268.64 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 6 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,550 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 29,370 | $24.26 | $712,516.20 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 5 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 28,617 | $45.32 | $1,296,922.44 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 4 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,832 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 41,464 | $20.50 | $850,012.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 3 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Tax withholdingCommon Stock | 93,500 | $45.32 | $4,237,420.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,985 F3 · kind: Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote 1. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:53 UTC | Catalent, Inc. CTLT · Entity 16279 | Exercise / conversionCommon Stock | 140,000 | $18.71 | $2,619,400.00 |
DisclosureSEC source: 0001596783-18-000152 · wf-form4_153860357769819.xml · nonDerivative · entry 1 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · balance_after: Includes restricted stock units. Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 15:57 UTC | Catalent, Inc. CTLT · Entity 16279 | GiftCommon Stock | 2,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000146 · wf-form4_153694062911409.xml · nonDerivative · entry 2 Chiminski John R · CIK 0001482197 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,485 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.